COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study
Status PubMed-not-MEDLINE Language English Country Switzerland Media electronic
Document type Journal Article
Grant support
LTC20031
Ministry of Education Youth and Sports
MUNI/A/1608/2020
Masaryk University
MUNI/IGA/1543/2020
Masaryk University
PubMed
34960183
PubMed Central
PMC8705445
DOI
10.3390/vaccines9121437
PII: vaccines9121437
Knihovny.cz E-resources
- Keywords
- COVID-19 vaccines, Czechia, booster immunization, decision making, health personnel,
- Publication type
- Journal Article MeSH
The emerging SARS-CoV-2 variants and waning vaccine-elicited immunity are two public health challenges that occurred simultaneously and synergistically during the summer of 2021 and led to a surging demand for COVID-19 vaccine booster dose (BD) rollout. This study aimed to evaluate the COVID-19 vaccine booster hesitancy (VBH) among Czech healthcare workers to explore the potential determinants of VBH. A national cross-sectional survey-based study was carried out between 3 and 11 November 2021, using an online self-administered questionnaire (SAQ) that explored the participants' demographic characteristics, COVID-19 infection and vaccine anamneses, willingness to receive COVID-19 vaccine BD, and the psychosocial drivers of VBH. A total of 3454 HCW properly responded to the online SAQ, of which 80.9% were females, 30.3% were medical professionals, and 50.5% were ≤47 years old. Most of the participants were already inoculated against SARS-CoV-2 (95.2%), and BTN162b2 was the most commonly administered vaccine (90.7%). As the study sample was planned to represent the target population, it revealed a high level of BD acceptance (71.3%) among Czech HCW, while 12.2% were still hesitant and 16.6% were against the currently available BD. These results are consistent with other recent results from central Europe. Medical professional, male, and older participants were more likely to accept BD rather than allied health professional, female, and younger participants. The BDs' perceived effectiveness against severe illness, symptomatic infection, and community transmission was a significant and strong predictor for BD acceptance, while the effectiveness against the circulating variants was not that important for our target population. The BDs' perceived safety and ethical dilemmas of vaccine justice should be addressed sufficiently while communicating with HCW and other population groups. The altruistic reasons for BD acceptance, i.e., family protection, patient protection, and community health protection, underpin the recommendation of postponing the COVID-19 vaccine mandating in favour of stressing these altruistic concerns amid public health messaging.
Department of Health Sciences Faculty of Medicine Masaryk University 625 00 Brno Czech Republic
Department of Public Health Faculty of Medicine Masaryk University 625 00 Brno Czech Republic
Institute of Health Information and Statistics of the Czech Republic 128 01 Prague Czech Republic
See more in PubMed
Centers for Disease Control and Prevention (CDC) COVID-19 Vaccine Booster Shots. [(accessed on 16 November 2021)]; Available online: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html.
Ministerstvo Zdravotnictví (MZCR) Posilovací a Dodatečná Dávka (Booster and Extra Doses) [(accessed on 16 November 2021)]; Available online: https://covid.gov.cz/situace/registrace-na-ockovani/posilovaci-dodatecna-davka.
Atwell J.E., Salmon D.A. Pertussis Resurgence and Vaccine Uptake: Implications for Reducing Vaccine Hesitancy. Pediatrics. 2014;134:602–604. doi: 10.1542/peds.2014-1883. PubMed DOI
Dasgupta P., Bhattacherjee S., Mukherjee A., Dasgupta S. Vaccine hesitancy for childhood vaccinations in slum areas of Siliguri, India. Indian J. Public Health. 2018;62:253. doi: 10.4103/IJPH.IJPH_397_17. PubMed DOI
Facciola A., Visalli G., Orlando A., Bertuccio M.P., Spataro P., Squeri R., Picerno I., Di Pietro A. Vaccine hesitancy: An overview on parents’ opinions about vaccination and possible reasons of vaccine refusal. J. Public Health Res. 2019;8:13–18. doi: 10.4081/jphr.2019.1436. PubMed DOI PMC
Chen X., Azman A.S., Lu W., Sun R., Zheng N., Ge S., Deng X., Yang J., Leung D.T., Yu H. Prediction of vaccine efficacy of the Delta variant. medRxiv. 2021 doi: 10.1101/2021.08.26.21262699. DOI
Lange B., Gerigk M., Tenenbaum T. Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers. N. Engl. J. Med. 2021;385:1145–1146. doi: 10.1056/NEJMc2108076. PubMed DOI PMC
Mizrahi B., Lotan R., Kalkstein N., Peretz A., Perez G., Ma M.N., Ben-Tov A., Chodick G., Gazit S., Patalon T. Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study. medRxiv. 2021 doi: 10.1101/2021.07.29.21261317. PubMed DOI PMC
Nasreen S., Chung H., He S., Brown K.A., Gubbay J.B., Buchan S.A., Fell D.B., Austin P.C., Schwartz K.L., Sundaram M.E., et al. Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada. medRxiv. 2021 doi: 10.1101/2021.06.28.21259420. DOI
Goldberg Y., Mandel M., Bar-On Y.M., Bodenheimer O., Freedman L., Haas E.J., Milo R., Alroy-Preis S., Ash N., Huppert A. Waning immunity of the BNT162b2 vaccine: A nationwide study from Israel. medRxiv. 2021 doi: 10.1101/2021.08.24.21262423. PubMed DOI PMC
Wall E.C., Wu M., Harvey R., Kelly G., Warchal S., Sawyer C., Daniels R., Hobson P., Hatipoglu E., Ngai Y., et al. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021;397:2331–2333. doi: 10.1016/S0140-6736(21)01290-3. PubMed DOI PMC
Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals | FDA. [(accessed on 16 November 2021)]; Available online: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised.
Sheikh A., McMenamin J., Taylor B., Robertson C. SARS-CoV-2 Delta VOC in Scotland: Demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021;397:2461–2462. doi: 10.1016/S0140-6736(21)01358-1. PubMed DOI PMC
Tartof S.Y., Slezak J.M., Fischer H., Hong V., Ackerson B.K., Ranasinghe O.N., Frankland T.B., Ogun O.A., Zamparo J.M., Gray S., et al. Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study. SSRN Electron. J. 2021 doi: 10.2139/ssrn.3909743. PubMed DOI PMC
Tang P., Hasan M.R., Chemaitelly H., Yassine H.M., Benslimane F.M., Khatib H.A.A., AlMukdad S., Coyle P., Ayoub H.H., Al Kanaani Z., et al. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar. medRxiv. 2021 doi: 10.1101/2021.08.11.21261885. PubMed DOI
Bernal J.L., Andrews N., Gower C., Gallagher E., Simmons R., Thelwall S., Stowe J., Tessier E., Groves N., Dabrera G., et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant. medRxiv. 2021 doi: 10.1101/2021.05.22.21257658. PubMed DOI PMC
Fowlkes A., Gaglani M., Groover K., Thiese M.S., Tyner H., Ellingson K. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance—Eight U.S. Locations, December 2020-August 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1167–1169. doi: 10.15585/mmwr.mm7034e4. PubMed DOI PMC
Bar-On Y.M., Goldberg Y., Mandel M., Bodenheimer O., Freedman L., Kalkstein N., Mizrahi B., Alroy-Preis S., Ash N., Milo R., et al. BNT162b2 vaccine booster dose protection: A nationwide study from Israel. medRxiv. 2021 doi: 10.1101/2021.08.27.21262679. PubMed DOI PMC
Silva-Cayetano A., Foster W.S., Innocentin S., Belij-Rammerstorfer S., Spencer A.J., Burton O.T., Fra-Bidó S., Le Lee J., Thakur N., Conceicao C., et al. A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice. Med. 2021;2:243–262.e8. doi: 10.1016/j.medj.2020.12.006. PubMed DOI PMC
Williams J.L., Christensen C.J., McMahon B.J., Bulkow L.R., Cagle H.H., Mayers J.S., Zanis C.L., Parkinson A.J., Margolis H.S. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. Vaccine. 2001;19:4081–4085. doi: 10.1016/S0264-410X(01)00112-8. PubMed DOI
Jayasundara D., Sheridan S., Randall D., Campbell P., Edmond K., Liu B., McIntyre P.B., Gidding H.F., Wood J.G. 472Long-term effectiveness of 3-dose primary course and 4-year booster dose of pertussis vaccine in Australia. Int. J. Epidemiol. 2021;50 doi: 10.1093/ije/dyab168.321. DOI
MacDonald N.E., Eskola J., Liang X., Chaudhuri M., Dube E., Gellin B., Goldstein S., Larson H., Manzo M.L., Reingold A., et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4164. doi: 10.1016/j.vaccine.2015.04.036. PubMed DOI
Rzymski P., Poniedziałek B., Fal A. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland. Vaccines. 2021;9:1286. doi: 10.3390/vaccines9111286. PubMed DOI PMC
Klugar M., Riad A., Mekhemar M., Conrad J., Buchbender M., Howaldt H.-P., Attia S. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology. 2021;10:752. doi: 10.3390/biology10080752. PubMed DOI PMC
Surgo Ventures Six Ways to Better Understand COVID-19 Vaccine Hesitancy. [(accessed on 17 November 2021)]. Available online: https://surgoventures.medium.com/six-ways-to-better-understand-covid-19-vaccine-hesitancy-3689dfd65b86.
Berg S. Which COVID-19 Vaccine Should I Get? What to Tell Your Patients. [(accessed on 17 November 2021)]. Available online: https://www.ama-assn.org/delivering-care/public-health/which-covid-19-vaccine-should-i-get-what-tell-your-patients.
World Economic Forum (WEF) Would You Get a COVID-19 Booster Shot if Offered? [(accessed on 16 November 2021)]. Available online: https://www.weforum.org/agenda/2021/09/covid-19-booster-shot-if-offered/
Díaz Crescitelli M.E., Ghirotto L., Sisson H., Sarli L., Artioli G., Bassi M.C., Appicciutoli G., Hayter M. A Meta-Synthesis Study of the Key Elements Involved in Childhood Vaccine Hesitancy. Volume 180. Public Health; London, UK: 2020. pp. 38–45. PubMed
Butler R., MacDonald N.E., Eskola J., Liang X., Chaudhuri M., Dube E., Gellin B., Goldstein S., Larson H., Manzo M.L., et al. Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP) Vaccine. 2015;33:4176–4179. doi: 10.1016/j.vaccine.2015.04.038. PubMed DOI
Strategic Advisory Group of Experts on Immunization (SAGE) Report of the Sage Working Group on Vaccine Hesitancy. SAGE; Thousand Oaks, CA, USA: 2014.
Lane S., MacDonald N.E., Marti M., Dumolard L. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017. Vaccine. 2018;36:3861–3867. doi: 10.1016/j.vaccine.2018.03.063. PubMed DOI PMC
Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS) [(accessed on 17 November 2021)]; Available online: https://vaers.hhs.gov/
Government of Canada (Canada.ca) Canadian Adverse Events Following Immunization Surveillance System (CAEFISS) [(accessed on 17 November 2021)]. Available online: https://www.canada.ca/en/public-health/services/immunization/canadian-adverse-events-following-immunization-surveillance-system-caefiss.html.
Medicines and Healthcare Products Regulatory Agency (MHRA) Coronavirus (COVID-19) Vaccines Adverse Reactions. [(accessed on 17 November 2021)]; Available online: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions.
Menni C., Klaser K., May A., Polidori L., Capdevila J., Louca P., Sudre C.H., Nguyen L.H., Drew D.A., Merino J., et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study. Lancet Infect. Dis. 2021;21:939–949. doi: 10.1016/S1473-3099(21)00224-3. PubMed DOI PMC
Jęśkowiak I., Wiatrak B., Grosman-Dziewiszek P., Szeląg A. The Incidence and Severity of Post-Vaccination Reactions after Vaccination against COVID-19. Vaccines. 2021;9:502. doi: 10.3390/vaccines9050502. PubMed DOI PMC
Riad A., Schünemann H., Attia S., Peričić T.P., Žuljević M.F., Jürisson M., Kalda R., Lang K., Morankar S., Yesuf E.A., et al. COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects. Int. J. Environ. Res. Public Health. 2021;18:7859. doi: 10.3390/ijerph18157859. PubMed DOI PMC
Klugar M., Riad A. COVID-19 Vaccines Safety Tracking (CoVaST) [(accessed on 15 July 2021)]; Available online: https://clinicaltrials.gov/ct2/show/NCT04834869. PubMed
Berg S. What Doctors Wish Patients Knew about COVID-19 Caccine Boosters. 2021. [(accessed on 17 November 2021)]. Available online: https://www.ama-assn.org/delivering-care/public-health/what-doctors-wish-patients-knew-about-covid-19-vaccine-boosters.
Bar-On Y.M., Goldberg Y., Mandel M., Bodenheimer O., Freedman L., Kalkstein N., Mizrahi B., Alroy-Preis S., Ash N., Milo R., et al. Protection of BNT162b2 Vaccine Booster against COVID-19 in Israel. N. Engl. J. Med. 2021;385:1393–1400. doi: 10.1056/NEJMoa2114255. PubMed DOI PMC
Dziedzic A., Riad A., Attia S., Klugar M., Tanasiewicz M. Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe. J. Clin. Med. 2021;10:5338. doi: 10.3390/jcm10225338. PubMed DOI PMC
Riad A., Pokorná A., Attia S., Klugarová J., Koščík M., Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J. Clin. Med. 2021;10:1428. doi: 10.3390/jcm10071428. PubMed DOI PMC
Riad A., Sağıroğlu D., Üstün B., Pokorná A., Klugarová J., Attia S., Klugar M. Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey. J. Clin. Med. 2021;10:2629. doi: 10.3390/jcm10122629. PubMed DOI PMC
Riad A., Hocková B., Kantorová L., Slávik R., Spurná L., Stebel A., Havriľak M., Klugar M. Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia. Pharmaceuticals. 2021;14:873. doi: 10.3390/ph14090873. PubMed DOI PMC
Alhazmi A., Alamer E., Daws D., Hakami M., Darraj M., Abdelwahab S., Maghfuri A., Algaissi A. Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines. 2021;9:674. doi: 10.3390/vaccines9060674. PubMed DOI PMC
Riad A., Pokorná A., Klugarová J., Antalová N., Kantorová L., Koščík M., Klugar M. Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18–30 Years Old): An Independent Post-Marketing Study. Pharmaceuticals. 2021;14:1049. doi: 10.3390/ph14101049. PubMed DOI PMC
Almufty H.B., Mohammed S.A., Abdullah A.M., Merza M.A. Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:102207. doi: 10.1016/j.dsx.2021.102207. PubMed DOI PMC
Riad A., Pokorná A., Mekhemar M., Conrad J., Klugarová J., Koščík M., Klugar M., Attia S. Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States. Vaccines. 2021;9:673. doi: 10.3390/vaccines9060673. PubMed DOI PMC
Boyarsky B.J., Werbel W.A., Avery R.K., Tobian A.A.R., Massie A.B., Segev D.L., Garonzik-Wang J.M. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021;325:2204–2206. doi: 10.1001/jama.2021.7489. PubMed DOI PMC
Marion O., Del Bello A., Abravanel F., Couat C., Faguer S., Esposito L., Hebral A.L., Izopet J., Kamar N. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Ann. Intern. Med. 2021;174:1336–1338. doi: 10.7326/M21-1341. PubMed DOI PMC
Kamar N., Abravanel F., Marion O., Couat C., Izopet J., Del Bello A. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. N. Engl. J. Med. 2021;385:661–662. doi: 10.1056/NEJMc2108861. PubMed DOI PMC
Monin L., Laing A.G., Muñoz-Ruiz M., McKenzie D.R., del Molino del Barrio I., Alaguthurai T., Domingo-Vila C., Hayday T.S., Graham C., Seow J., et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: Interim analysis of a prospective observational study. Lancet Oncol. 2021;22:765–778. doi: 10.1016/S1470-2045(21)00213-8. PubMed DOI PMC
KoBoToolbox.org KoBoToolbox. [(accessed on 15 August 2020)]. Available online: https://support.kobotoolbox.org/welcome.html.
Von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. UroToday Int. J. 2007;335:806–808. doi: 10.1097/EDE.0b013e3181577654. PubMed DOI PMC
Česká Lékařská Společnost Jana Evangelisty Purkyně (CzMA) Společnosti ČLS JEP, z.s (Member Societies of the Czech Medical Association) [(accessed on 15 November 2021)]. Available online: https://www.cls.cz/spolecnosti-cls-jep.
CZECRIN Czech Clinical Research Infrastructure Network. [(accessed on 2 March 2021)]. Available online: https://czecrin.cz/en/home/
Ústav Zdravotnických Informací a Statistiky České Republiky (ÚZIS ČR) Systém Hlášení Nežádoucích Událostí (SHNU) [(accessed on 8 March 2021)]. Available online: https://shnu.uzis.cz/
Česká Asociace Sester (CNNA) Postoje Zdravotnických Pracovníků ke Třetím (Posilovacím) Dávkám Očkování Proti COVID-19. [(accessed on 15 November 2021)]. Available online: https://www.cnna.cz/
Nás|UNIFY ČR. [(accessed on 17 November 2021)]. Available online: http://www.unify-cr.cz/o-nas.
ČKPA—Česká Komora Porodních Asistentek z.s. [(accessed on 17 November 2021)]. Available online: https://www.ckpa.cz/
SVVS—Kdo Jsme. [(accessed on 17 November 2021)]. Available online: https://www.svvs.cz/
Avvnzp. [(accessed on 17 November 2021)]. Available online: https://avvnzp.webnode.cz/
Dokumenty APSS ČR—Asociace|Asociace Poskytovatelů Sociálních Služeb České Republiky. [(accessed on 17 November 2021)]. Available online: https://www.apsscr.cz/cz/asociace/dokumenty-apss-cr.
Ministerstvo zdravotnictví České republiky (MZČR) Dotazníkový Průzkum: Postoje Zdravotnických Pracovníků ke Třetím (Posilovacím) Dávkám Očkování Proti COVID-19. [(accessed on 15 November 2021)]; Available online: https://www.mzcr.cz/dotaznik-postoje-zdravotnickych-pracovniku-treti-davka-ockovani-covid-19/
Centers for Disease Control and Prevention (CDC) Epi Info™ for Windows. [(accessed on 25 December 2020)]; Available online: https://www.cdc.gov/epiinfo/pc.html.
Centers for Disease Control and Prevention (CDC) Population Survey or Descriptive Study. [(accessed on 19 May 2021)]; Available online: https://www.cdc.gov/epiinfo/user-guide/statcalc/samplesize.html.
Institute of Health Information and Statistics of the Czech Republic (UZIS) Health Yearbook of the Czech Republic 2017. [(accessed on 3 March 2021)]. Available online: https://www.uzis.cz/index-en.php?pg=record&id=8166.
Riad A., Abdulqader H., Morgado M., Domnori S., Koščík M., Mendes J.J., Klugar M., Kateeb E. Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy. Vaccines. 2021;9:566. doi: 10.3390/vaccines9060566. PubMed DOI PMC
Riad A., Huang Y., Abdulqader H., Morgado M., Domnori S., Koščík M., Mendes J.J., Klugar M., Kateeb E. IADS-SCORE Universal Predictors of Dental Students’ Attitudes towards COVID-19 Vaccination: Machine Learning-Based Approach. Vaccines. 2021;9:1158. doi: 10.3390/vaccines9101158. PubMed DOI PMC
Riad A., Pokorná A., Antalová N., Krobot M., Zviadadze N., Serdiuk I., Koščík M., Klugar M. Prevalence and Drivers of COVID-19 Vaccine Hesitancy among Czech University Students: National Cross-Sectional Study. Vaccines. 2021;9:948. doi: 10.3390/vaccines9090948. PubMed DOI PMC
Kateeb E., Danadneh M., Pokorná A., Klugarová J., Abdulqader H., Klugar M., Riad A. Predictors of Willingness to Receive COVID-19 Vaccine: Cross-Sectional Study of Palestinian Dental Students. Vaccines. 2021;9:954. doi: 10.3390/vaccines9090954. PubMed DOI PMC
Štěpánek L., Janošíková M., Nakládalová M., Štěpánek L., Boriková A., Vildová H. Motivation to COVID-19 Vaccination and Reasons for Hesitancy in Employees of a Czech Tertiary Care Hospital: A Cross-Sectional Survey. Vaccines. 2021;9:863. doi: 10.3390/vaccines9080863. PubMed DOI PMC
Trent M., Seale H., Chughtai A., Salmon D., MacIntyre C. Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia. Vaccine. 2021 doi: 10.1016/j.vaccine.2021.06.048. in press. PubMed DOI PMC
Murphy J., Vallières F., Bentall R.P., Shevlin M., McBride O., Hartman T.K., McKay R., Bennett K., Mason L., Gibson-Miller J., et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat. Commun. 2021;12:29. doi: 10.1038/s41467-020-20226-9. PubMed DOI PMC
Salerno L., Craxì L., Amodio E., Lo Coco G. Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy. Vaccines. 2021;9:927. doi: 10.3390/vaccines9080927. PubMed DOI PMC
McHugh M.L. Interrater reliability: The kappa statistic. Biochem. Med. 2012;22:276–282. doi: 10.11613/BM.2012.031. PubMed DOI PMC
(WMA) W.M.A. World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA J. Am. Med. Assoc. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053. PubMed DOI
Proton Technologies AG General Data Protection Regulation (GDPR) Compliance Guidelines. [(accessed on 1 May 2020)]. Available online: https://gdpr.eu/
SPSS Inc IBM SPSS Statistics 28. [(accessed on 14 March 2021)]. Available online: https://www.ibm.com/support/pages/ibm-spss-statistics-28-documentation.
AION-CS 95/2004 Sb. Zákon o Podmínkách Získávání a Uznávání Způsobilosti k Výkonu Povolání Lékařů a Farmaceutů. [(accessed on 15 November 2021)]. Available online: https://www.zakonyprolidi.cz/cs/2004-95.
AION-CS 96/2004 Sb. Zákon o Nelékařských Zdravotnických Povoláních. [(accessed on 15 November 2021)]. Available online: https://www.zakonyprolidi.cz/cs/2004-96.
Ústav Zdravotnických Informací a Statistiky ČR (ÚZIS) Rozlišení Lékařských a Nelékařských Zdravotnických Povolání: Lékař, Sestra a Další Nelékařská Povolání. [(accessed on 15 November 2021)]. Available online: https://www.nzip.cz/clanek/479-lekarska-vs-nelekarska-zdravotnicka-povolani.
AION-CS 129/2000 Sb. Zákon o Krajích. [(accessed on 15 November 2021)]. Available online: https://www.zakonyprolidi.cz/cs/2000-129.
NHMRC N.H., M.R.C Australian Guidelines for the Clinical Care of People with COVID-19. [(accessed on 17 September 2020)]; Available online: https://www.clinicalguidelines.gov.au/register/australian-guidelines-clinical-care-people-covid-19.
Sugawara N., Yasui-Furukori N., Fukushima A., Shimoda K., Diclemente J. Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine? Vaccines. 2021;9:1295. doi: 10.3390/vaccines9111295. PubMed DOI PMC
Czech Statistical Office (CZSO) Zaostřeno na Ženy a Muže 2018 (Focus on Women and Men 2018) [(accessed on 17 November 2021)]. Available online: https://www.czso.cz/documents/10180/60622084/30000218.pdf.
Czech Statistical Office (CZSO) Odměňování Zdravotnických Pracovníků (Remuneration of Healthcare Staff) [(accessed on 17 November 2021)]. Available online: https://www.czso.cz/documents/10180/112643651/260024-19.pdf.
Worldmeter Coronavirus Update (Live) [(accessed on 17 November 2021)]. Available online: https://www.worldometers.info/coronavirus/
Jarkovsky J., Benesova K., Cerny V., Razova J., Kala P., Dolina J., Majek O., Sebestova S., Bezdekova M., Melicharova H., et al. Covidogram as a simple tool for predicting severe course of COVID-19: Population-based study. BMJ Open. 2021;11:e045442. doi: 10.1136/bmjopen-2020-045442. PubMed DOI PMC
Komenda M., Bulhart V., Karolyi M., Jarkovský J., Mužík J., Májek O., Šnajdrová L., Růžičková P., Rážová J., Prymula R., et al. Complex reporting of the COVID-19 epidemic in the czech republic: Use of an interactive web-based app in practice. J. Med. Internet Res. 2020;22:e19367. doi: 10.2196/19367. PubMed DOI PMC
COVID-19 v ČR: Otevřené Datové Sady a Sady ke Stažení | Onemocnění Aktuálně od MZČR. [(accessed on 17 November 2021)]. Available online: https://onemocneni-aktualne.mzcr.cz/api/v2/covid-19.
Shatnawi N.J., Mesmar Z., Al-Omari G.A., AL-Sheyab W., AlZoubi N.A., AL-Ghazo M., Hamouri S., AL-Faori I., Bani-Essa A., Matalka I., et al. Compliance with safety measures and risk of COVID-19 transmission among healthcare workers. Future Sci. OA. 2021 doi: 10.2144/fsoa-2021-0094. PubMed DOI PMC
Lai X., Wang X., Yang Q., Xu X., Tang Y., Liu C., Tan L., Lai R., Wang H., Zhang X., et al. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China? Antimicrob. Resist. Infect. Control. 2020;9:83. doi: 10.1186/s13756-020-00746-1. PubMed DOI PMC
Ashinyo M.E., Dubik S.D., Duti V., Amegah K.E., Ashinyo A., Asare B.A., Ackon A.A., Akoriyea S.K., Kuma-Aboagye P. Infection prevention and control compliance among exposed healthcare workers in COVID-19 treatment centers in Ghana: A descriptive cross-sectional study. PLoS ONE. 2021;16:e0248282. doi: 10.1371/journal.pone.0248282. PubMed DOI PMC
Keehner J., Horton L.E., Pfeffer M.A., Longhurst C.A., Schooley R.T., Currier J.S., Abeles S.R., Torriani F.J. SARS-CoV-2 Infection after Vaccination in Health Care Workers in California. N. Engl. J. Med. 2021;384:1774–1775. doi: 10.1056/NEJMc2101927. PubMed DOI PMC
Gohil S.K., Olenslager K., Quan K.A., Dastur C.K., Afsar N., Chang W., Huang S.S. Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination. JAMA Netw. Open. 2021;4:e2115980. doi: 10.1001/jamanetworkopen.2021.15980. PubMed DOI PMC
Gilboa M., Tal I., Levin E.G., Segal S., Belkin A., Zilberman-Daniels T., Biber A., Rubin C., Rahav G., Regev-Yochay G. Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers. Infect. Control Hosp. Epidemiol. 2021:1–6. doi: 10.1017/ice.2021.421. PubMed DOI PMC
Lee J.T., Althomsons S.P., Wu H., Budnitz D.S., Kalayil E.J., Lindley M.C., Pingali C., Bridges C.B., Geller A.I., Fiebelkorn A.P., et al. Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network—United States, March 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1036–1039. doi: 10.15585/mmwr.mm7030a2. PubMed DOI PMC
Sallam M. Covid-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines. 2021;9:160. doi: 10.3390/vaccines9020160. PubMed DOI PMC
Solís Arce J.S., Warren S.S., Meriggi N.F., Scacco A., McMurry N., Voors M., Syunyaev G., Malik A.A., Aboutajdine S., Adeojo O., et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat. Med. 2021;27:1385–1394. doi: 10.1038/s41591-021-01454-y. PubMed DOI PMC
Ministerstvo Zdravotnictví ČR (MZČR) COVID-19: Přehled Vykázaných Očkování v ČR. [(accessed on 10 November 2021)]. Available online: https://onemocneni-aktualne.mzcr.cz/vakcinace-cr.
Finney Rutten L.J., Zhu X., Leppin A.L., Ridgeway J.L., Swift M.D., Griffin J.M., St. Sauver J.L., Virk A., Jacobson R.M. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy. Mayo Clin. Proc. 2021;96:699–707. doi: 10.1016/j.mayocp.2020.12.024. PubMed DOI PMC
Kuter B.J., Browne S., Momplaisir F.M., Feemster K.A., Shen A.K., Green-McKenzie J., Faig W., Offit P.A. Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia. Vaccine. 2021;39:1693–1700. doi: 10.1016/j.vaccine.2021.02.029. PubMed DOI PMC
Schernhammer E., Weitzer J., Laubichler M.D., Birmann B.M., Bertau M., Zenk L., Caniglia G., Jäger C.C., Steiner G. Correlates of COVID-19 vaccine hesitancy in Austria: Trust and the government. J. Public Health. 2021:fdab122. doi: 10.1093/pubmed/fdab122. PubMed DOI PMC
Gur-Arie R., Jamrozik E., Kingori P. No Jab, No Job? Ethical Issues in Mandatory COVID-19 Vaccination of Healthcare Personnel. BMJ Glob. Health. 2021;6:e004877. doi: 10.1136/bmjgh-2020-004877. PubMed DOI PMC
Barda N., Dagan N., Cohen C., Hernán M.A., Lipsitch M., Kohane I.S., Reis B.Y., Balicer R.D. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: An observational study. Lancet. 2021;398:2093–2100. doi: 10.1016/S0140-6736(21)02249-2. PubMed DOI PMC
Flanagan K.L., Fink A.L., Plebanski M., Klein S.L. Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. Annu. Rev. Cell Dev. Biol. 2017;33:577–599. doi: 10.1146/annurev-cellbio-100616-060718. PubMed DOI
Klein S.L., Jedlicka A., Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect. Dis. 2010;10:338–349. doi: 10.1016/S1473-3099(10)70049-9. PubMed DOI PMC
Gadoth A., Halbrook M., Martin-Blais R., Gray A., Tobin N.H., Ferbas K.G., Aldrovandi G.M., Rimoin A.W. Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles. Ann. Intern. Med. 2021;174:882–885. doi: 10.7326/M20-7580. PubMed DOI PMC
Keske Ş., Mutters N.T., Tsioutis C., Ergönül Ö. Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic. Vaccine. 2020;38:8357–8361. doi: 10.1016/j.vaccine.2020.11.003. PubMed DOI
Hollmeyer H.G., Hayden F., Poland G., Buchholz U. Influenza vaccination of health care workers in hospitals--a review of studies on attitudes and predictors. Vaccine. 2009;27:3935–3944. doi: 10.1016/j.vaccine.2009.03.056. PubMed DOI
Pless A., McLennan S.R., Nicca D., Shaw D.M., Elger B.S. Reasons why nurses decline influenza vaccination: A qualitative study. BMC Nurs. 2017;16:20. doi: 10.1186/s12912-017-0215-5. PubMed DOI PMC
World Health Organization (WHO) Media Briefing on COVID-19. [(accessed on 17 November 2021)]. Available online: https://www.youtube.com/watch?v=L3fNLTJT4GU&t=3s&ab_channel=WorldHealthOrganization%28WHO%29.
Hotez P.J., Batista C., Amor Y.B., Ergonul O., Figueroa J.P., Gilbert S., Gursel M., Hassanain M., Kang G., Kaslow D.C., et al. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic. EClinicalMedicine. 2021;39:101053. doi: 10.1016/j.eclinm.2021.101053. PubMed DOI PMC
WHO-SAGE Interim Statement on Booster Doses for COVID-19 Vaccination. [(accessed on 17 November 2021)]. Available online: https://www.who.int/news/item/04-10-2021-interim-statement-on-booster-doses-for-covid-19-vaccination.
Parente D.J., Ojo A., Gurley T., Le Master J.W., Meyer M., Wild D.M., Mustafa R.A. Acceptance of COVID-19 Vaccination Among Health System Personnel. J. Am. Board Fam. Med. 2021;34:498–508. doi: 10.3122/jabfm.2021.03.200541. PubMed DOI
Rey D., Fressard L., Cortaredona S., Bocquier A., Gautier A., Peretti-Watel P., Verger P. Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance. Eurosurveillance. 2018;23:17-00816. doi: 10.2807/1560-7917.ES.2018.23.17.17-00816. PubMed DOI PMC
